Cargando…

Polymorphism of E6 and E7 Genes in Human Papillomavirus Types 31 and 33 in Northeast China

Persistent infection with human papillomavirus (HPV) types 31 and 33 is an important causative factor for cervical cancer. The E6/E7 genes are key oncogenes involved in the immortalization and transformation of human epithelial cells. Genetic polymorphism may lead to differences in the virus' c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Miao, Wu, Si, Wang, Shuang, Cui, Changwan, Lu, Yiping, Sun, Zhengrong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027458/ https://www.ncbi.nlm.nih.gov/pubmed/36950084 http://dx.doi.org/10.1155/2023/9338294

Ejemplares similares

E6 and E7 Gene Polymorphisms in Human Papillomavirus Types-58 and 33 Identified in Southwest China
por: Chen, Zuyi, et al.
Publicado: (2017)

Correction: E6 and E7 Gene Polymorphisms in Human Papillomavirus Types-58 and 33 Identified in Southwest China
por: Chen, Zuyi, et al.
Publicado: (2017)

E6 and E7 gene polymorphisms in human papillomavirus Type-6 identified in Southwest China
por: Chen, Zuyi, et al.
Publicado: (2019)

Genomic Polymorphism of Human Papillomavirus Type 52 in Women from Northeast China
por: Sun, Zhengrong, et al.
Publicado: (2012)

Human papillomavirus E6 and E7: What remains?
por: Vats, Arushi, et al.
Publicado: (2021)

Gene Expression Along with Genomic Copy Number Variation and Mutational Analysis Were Used to Develop a 9-Gene Signature for Estimating Prognosis of COAD
por: Lu, Yiping, et al.
Publicado: (2020)

Identification of variants and therapeutic epitopes in HPV-33/HPV-58 E6 and E7 in Southwest China
por: He, Jiaoyu, et al.
Publicado: (2019)

Genetic variability of human papillomavirus type 39 based on E6, E7 and L1 genes in Southwest China
por: He, Jiaoyu, et al.
Publicado: (2021)

Genetic variation of E6 and E7 genes of human papillomavirus type 16 from central China
por: Li, Ting, et al.
Publicado: (2023)

Phylogeny and polymorphism in the E6 and E7 of human papillomavirus: alpha-9 (HPV16, 31, 33, 52, 58), alpha-5 (HPV51), alpha-6 (HPV53, 66), alpha-7 (HPV18, 39, 59, 68) and alpha-10 (HPV6, 44) in women from Shanghai
por: Zhao, Junwei, et al.
Publicado: (2019)

Human Papillomavirus E6/E7 Expression in Preeclampsia-Affected Placentae
por: Reily-Bell, Ashley L., et al.
Publicado: (2020)

The genetic variability, phylogeny and functional significance of E6, E7 and LCR in human papillomavirus type 52 isolates in Sichuan, China
por: Song, Zhilin, et al.
Publicado: (2021)

Cervical carcinogenesis risk association of HPV33 E6 and E7 genetic variations in Taizhou, Southeast China
por: Yan, Zi-Yi, et al.
Publicado: (2023)

Performance of human papillomavirus E6/E7 mRNA assay for primary cervical cancer screening and triage: Population-based screening in China
por: Zhang, Jing, et al.
Publicado: (2022)

Transforming Properties of Beta-3 Human Papillomavirus E6 and E7 Proteins
por: Minoni, Lucia, et al.
Publicado: (2020)

Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy
por: Pal, Asmita, et al.
Publicado: (2020)

REBACIN(®) inhibits E6/E7 oncogenes in clearance of human papillomavirus infection
por: Zhou, Shu-Guang, et al.
Publicado: (2022)

The polymorphisms of LCR, E6, and E7 of HPV-58 isolates in Yunnan, Southwest China
por: Xi, Juemin, et al.
Publicado: (2018)

STAT1 expression and HPV16 viral load predict cervical lesion progression
por: Wu, Si, et al.
Publicado: (2020)

Diversity of cervicovaginal human papillomavirus (HPV) genotypes and naturally occurring E6/E7 DNA polymorphisms of HPV-16 in Ghana
por: Kaba, Gladys, et al.
Publicado: (2023)

Separate analysis of human papillomavirus E6 and E7 messenger RNAs to predict cervical neoplasia progression
por: Liu, Shuling, et al.
Publicado: (2018)

Genetic variability of E6 and E7 genes of human papillomavirus type 58 in Jingzhou, Hubei Province of central China
por: Yang, Zhiping, et al.
Publicado: (2022)

Genetic diversity of E6, E7 and the long control region in human papillomavirus type 16 variants in Beijing, China
por: Wang, Jiao, et al.
Publicado: (2022)

Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker
por: Fontecha, Nerea, et al.
Publicado: (2016)

Modulation of DNA methylation by human papillomavirus E6 and E7 oncoproteins in cervical cancer
por: Sen, Prakriti, et al.
Publicado: (2018)

RNA extraction method is crucial for human papillomavirus E6/E7 oncogenes detection
por: Fontecha, Nerea, et al.
Publicado: (2017)

Regulation of the Wnt/β-Catenin Signaling Pathway by Human Papillomavirus E6 and E7 Oncoproteins
por: Muñoz Bello, Jesus Omar, et al.
Publicado: (2015)

Human Papillomavirus 16 E6 and E7 Synergistically Repress Innate Immune Gene Transcription
por: James, Claire D., et al.
Publicado: (2020)

High-Risk Human Papillomavirus Oncogenic E6/E7 mRNAs Splicing Regulation
por: Zheng, Yunji, et al.
Publicado: (2022)

Genetic Variability in the E6/E7 Region of Human Papillomavirus 16 in Women from Ecuador
por: Zhingre, Alicia, et al.
Publicado: (2023)

Performance of the Human Papillomavirus E6/E7 mRNA Assay in the Primary Screening of Cervical Cancer: Opportunistic Screening in Fujian, China
por: Zhuang, Lijuan, et al.
Publicado: (2022)

Genetic variations of E6 and long control region of human papillomavirus type 16 from patients with cervical lesion in Liaoning, China
por: Sun, Zhengrong, et al.
Publicado: (2013)

E6^E7, a Novel Splice Isoform Protein of Human Papillomavirus 16, Stabilizes Viral E6 and E7 Oncoproteins via HSP90 and GRP78
por: Ajiro, Masahiko, et al.
Publicado: (2015)

E6/E7 Variants of Human Papillomavirus 16 Associated with Cervical Carcinoma in Women in Southern Mexico
por: Antaño-Arias, Ramón, et al.
Publicado: (2021)

Genetic variations in E6, E7 and the long control region of human papillomavirus type 16 among patients with cervical lesions in Xinjiang, China
por: Zhe, Xiangyi, et al.
Publicado: (2019)

The Role of E6 Spliced Isoforms (E6*) in Human Papillomavirus-Induced Carcinogenesis
por: Olmedo-Nieva, Leslie, et al.
Publicado: (2018)

Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein
por: Laurson, Joanna, et al.
Publicado: (2010)

The human papillomavirus E6 and E7 inducible oncogene, hWAPL, exhibits potential as a therapeutic target
por: Kuroda, M, et al.
Publicado: (2005)

Tattoo Delivery of a Semliki Forest Virus-Based Vaccine Encoding Human Papillomavirus E6 and E7
por: van de Wall, Stephanie, et al.
Publicado: (2015)

Upregulation of PIR gene expression induced by human papillomavirus E6 and E7 in epithelial oral and cervical cells
por: Carrillo, Diego, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ppjamev11l6hmd1d3336k3riqg